Evoke Pharma (EVOK) Misses Q4 EPS by 9c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.59), $0.09 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.63 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• RH (RH) Tops Q1 EPS by 12c
• United Community Banks sells equipment finance unit for $1.9 billion